Free Trial

LogicMark (LGMK) Competitors

LogicMark logo
$0.0030 0.00 (-6.25%)
As of 07/3/2025 12:58 PM Eastern

LGMK vs. CODX, SINT, POAI, LFWD, TNON, STRR, LUCY, AMIX, BLAC, and QNRX

Should you be buying LogicMark stock or one of its competitors? The main competitors of LogicMark include Co-Diagnostics (CODX), Sintx Technologies (SINT), Predictive Oncology (POAI), Lifeward (LFWD), Tenon Medical (TNON), Star Equity (STRR), Innovative Eyewear (LUCY), Autonomix Medical (AMIX), Bellevue Life Sciences Acquisition (BLAC), and Quoin Pharmaceuticals (QNRX). These companies are all part of the "medical equipment" industry.

LogicMark vs. Its Competitors

Co-Diagnostics (NASDAQ:CODX) and LogicMark (NASDAQ:LGMK) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

Co-Diagnostics has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, LogicMark has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500.

15.0% of Co-Diagnostics shares are owned by institutional investors. Comparatively, 7.9% of LogicMark shares are owned by institutional investors. 8.4% of Co-Diagnostics shares are owned by company insiders. Comparatively, 1.3% of LogicMark shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

LogicMark has a net margin of -141.96% compared to Co-Diagnostics' net margin of -1,025.45%. Co-Diagnostics' return on equity of -60.16% beat LogicMark's return on equity.

Company Net Margins Return on Equity Return on Assets
Co-Diagnostics-1,025.45% -60.16% -52.69%
LogicMark -141.96%-124.91%-92.05%

LogicMark has higher revenue and earnings than Co-Diagnostics. Co-Diagnostics is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Co-Diagnostics$3.91M2.46-$37.64M-$1.17-0.25
LogicMark$9.88M0.17-$14.55M-$223.500.00

Co-Diagnostics currently has a consensus price target of $5.50, suggesting a potential upside of 1,816.38%. Given Co-Diagnostics' stronger consensus rating and higher probable upside, equities analysts clearly believe Co-Diagnostics is more favorable than LogicMark.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Co-Diagnostics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
LogicMark
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Co-Diagnostics' average media sentiment score of 0.00 equaled LogicMark'saverage media sentiment score.

Company Overall Sentiment
Co-Diagnostics Neutral
LogicMark Neutral

Summary

Co-Diagnostics beats LogicMark on 10 of the 15 factors compared between the two stocks.

Get LogicMark News Delivered to You Automatically

Sign up to receive the latest news and ratings for LGMK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LGMK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LGMK vs. The Competition

MetricLogicMarkSurgical appliances & supplies IndustryIndustrials SectorNASDAQ Exchange
Market Cap$1.84M$28.19M$7.52B$8.95B
Dividend YieldN/AN/A4.55%4.08%
P/E Ratio0.0012.8424.9520.24
Price / Sales0.172.39116.16118.25
Price / CashN/A12.8027.3557.47
Price / Book0.002.334.355.67
Net Income-$14.55M-$5.31M$791.63M$248.47M
7 Day PerformanceN/A-2.47%2.37%3.32%
1 Month PerformanceN/A-9.06%5.68%5.20%
1 Year PerformanceN/A-4.85%32.63%21.35%

LogicMark Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LGMK
LogicMark
0.3186 of 5 stars
$0.00
-6.3%
N/A-100.0%$1.84M$9.88M0.0020
CODX
Co-Diagnostics
4.2155 of 5 stars
$0.28
+6.7%
$5.50
+1,862.9%
-77.6%$8.81M$3.91M-0.24100Gap Up
SINT
Sintx Technologies
2.4089 of 5 stars
$3.22
flat
$28.00
+769.6%
-28.5%$8.08M$2.89M-0.0640
POAI
Predictive Oncology
2.1601 of 5 stars
$0.83
+0.0%
$3.00
+261.4%
-15.6%$7.41M$1.62M-0.2730
LFWD
Lifeward
2.8358 of 5 stars
$0.64
-3.8%
$9.00
+1,295.8%
-81.9%$7.38M$25.66M-0.2160High Trading Volume
TNON
Tenon Medical
1.4473 of 5 stars
$0.98
+2.9%
$4.67
+377.5%
+29.0%$7.21M$3.28M-0.048
STRR
Star Equity
3.6064 of 5 stars
$2.00
-1.0%
$5.00
+150.0%
-50.9%$6.48M$53.36M-0.58460
LUCY
Innovative Eyewear
0.5087 of 5 stars
$2.12
+1.9%
N/A-77.0%$6.44M$1.64M-0.539Gap Down
AMIX
Autonomix Medical
3.2951 of 5 stars
$1.57
-21.9%
$16.50
+951.0%
-89.0%$5.59MN/A-0.211Positive News
Gap Down
High Trading Volume
BLAC
Bellevue Life Sciences Acquisition
N/A$1.35
+8.0%
N/A-87.1%$5.46MN/A0.00N/AGap Down
High Trading Volume
QNRX
Quoin Pharmaceuticals
0.5396 of 5 stars
$9.23
-0.4%
N/A-55.2%$5.45MN/A-0.194Gap Down

Related Companies and Tools


This page (NASDAQ:LGMK) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners